Article(id=1322631289249845808, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1322631259684192984, articleNumber=null, orderNo=null, doi=10.7501j.issn.0253-2670.2026.19.030, pmid=null, cstr=null, oa=null, hot=0, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1779724800000, receivedDateStr=2026-05-26, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793269472658, onlineDateStr=2026-10-29, pubDate=null, pubDateStr=null, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793269472658, onlineIssueDateStr=2026-10-29, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793269472658, creator=13701087609, updateTime=1793269472658, updator=13701087609, issue=Issue{id=1322631259684192984, tenantId=1146029695717560320, journalId=1302319053441957962, year='2026', volume='57', issue='19', pageStart='7501', pageEnd='7928', issueExtLink='null', onlineDate='null', pubDate='1791734400000', pubDateStr='2026-10-12', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=1, specialIssue=null, createTime=1793269465608, creator='13701087609', updateTime=1793269554856, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1322631634101326494, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1322631259684192984, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1322631634101326495, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1322631259684192984, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=7877, endPage=7885, ext={EN=ArticleExt(id=1322631289551835698, articleId=1322631289249845808, tenantId=1146029695717560320, journalId=1302319053441957962, language=EN, title=Key strategies for innovative drug development in global competition: Jiangxi’s traditional Chinese medicine modernization and biologics/antibody collaborative innovation, columnId=null, journalTitle=Chinese Traditional and Herbal Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=Against the backdrop of accelerated innovation in the global biomedical sector and China’s transition toward innovation-driven development in the pharmaceutical industry, Jiangxi province—with its profound traditional Chinese medicine heritage and industrial foundation characterized by “one city, one capital, and multiple parks”—faces both opportunities and challenges. Prominent issues include the relatively small scale of emerging fields such as biologics and antibody drugs, insufficient clustering of high-end innovation factors, and low efficiency in translating research outcomes into applications. To study these challenges, this study employs methods such as literature review, case analysis, and comparative research to systematically assess the current status and core weaknesses of Jiangxi’s innovative drug industry. It further proposes a differentiated development pathway centered on “modernizing traditional Chinese medicine as the foundation while promoting differentiated and coordinated development of biologics and antibody drugs.” The study recommends that Jiangxi should focus on advancing the digital and intelligent transformation and standardization of the entire TCM industry chain, cultivate blockbuster pharmaceutical products with a market scale of RMB 10 billion, implement a gradient layout in key areas such as cell therapy and antibody-drug conjugate drugs, and build a synergistic innovation ecosystem integrating “talent, capital, platforms, and policies,” with strengthened clinical translation and financial support. These measures will enable the transition from a “major pharmaceutical province” to a “strong pharmaceutical province.”, authors=YANG Suleixin1, LI Jingyuan1, WANG Meilin2, CHEN Lin1, ZHOU Xiang3, YANG Ming3, WANG Shiyong4, CHEN Shilin1, authorsList=YANG Suleixin, LI Jingyuan, WANG Meilin, CHEN Lin, ZHOU Xiang, YANG Ming, WANG Shiyong, CHEN Shilin, authorCompany=1 Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China;
2 Southwest Minzu University, Chengdu 610041, China;
3 Jiangxi University of Chinese Medicine, Nanchang 330004, China;
4 Jiangxi Institute of Scientific & Technical Information, Nanchang 330046, China, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1322631289476338225, articleId=1322631289249845808, tenantId=1146029695717560320, journalId=1302319053441957962, language=CN, title=全球竞争视角下创新药产业重点赛道发展策略——江西省中药现代化转型与生物药/抗体药物协同创新路径, columnId=1304140194685415572, journalTitle=中草药, columnName=综述, runingTitle=null, highlight=null, articleAbstract=在全球生物医药创新加速与中国医药产业向创新驱动转型的背景下,江西省依托深厚的中医药底蕴和“一城一都多园”的产业基础,迎来发展机遇,但也面临生物药与抗体药物等新兴领域规模偏小、高端要素集聚不足、成果转化效率不高等突出问题。运用文献研究、案例分析与比较研究等方法,系统评估了江西省创新药产业的发展现状与核心短板,进而提出“中药现代化为根基,生物药与抗体药物错位协同”的差异化发展路径。建议江西应重点推动中药全产业链数智升级与标准化,培育百亿级大品种,聚焦细胞治疗、抗体-药物偶联物等赛道实施梯度布局,并通过构建“人才-资本-平台-政策”协同的创新生态,强化临床转化与金融支撑,实现从“医药大省”到“医药强省”的跨越。, authors=杨苏瓃鑫1, 李婧媛1, 王美林2, 陈林1, 周翔3, 杨明3, 汪仕勇4, 陈士林1, authorsList=杨苏瓃鑫, 李婧媛, 王美林, 陈林, 周翔, 杨明, 汪仕勇, 陈士林, authorCompany=1 成都中医药大学, 四川 成都 611137;
2 西南民族大学, 四川 成都 610041;
3 江西中医药大学, 江西 南昌 330004;
4 江西省科技信息研究所, 江西 南昌 330046, correspAuthors=陈士林, authorNote=杨苏瓃鑫: 杨苏瓃鑫,副研究员,硕士生导师,从事药物化学与递送系统开发研究。E-mail:yangsulation@cdutcm.edu.cn 李婧媛: 李婧媛,硕士研究生,研究方向为中医药与现代生物学交叉。E-mail:lijingyuan2025@163.com, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=wt5Gv9edmSe0nUrI22tmHQ==, pdfFileSize=1078244, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=中国工程院咨询项目“江西省创新药重点发展方向及布局研究” (2025-02JXZD-05))}, authors=null, keywords=[Keyword(id=1322634686367642102, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631289249845808, language=CN, orderNo=1, keyword=江西省), Keyword(id=1322634686434750967, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631289249845808, language=CN, orderNo=2, keyword=创新药), Keyword(id=1322634686522831352, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631289249845808, language=CN, orderNo=3, keyword=中医药现代化), Keyword(id=1322634686594134521, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631289249845808, language=CN, orderNo=4, keyword=生物制品/抗体药物), Keyword(id=1322634686661243386, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631289249845808, language=CN, orderNo=5, keyword=全球视角), Keyword(id=1322634686837404155, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631289249845808, language=EN, orderNo=1, keyword=Jiangxi province), Keyword(id=1322634686904513020, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631289249845808, language=EN, orderNo=2, keyword=innovative drugs), Keyword(id=1322634686975816189, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631289249845808, language=EN, orderNo=3, keyword=modernization of traditional Chinese medicine), Keyword(id=1322634687063896574, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631289249845808, language=EN, orderNo=4, keyword=biologics/antibody drugs), Keyword(id=1322634687131005439, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631289249845808, language=EN, orderNo=5, keyword=global perspective)], refs=null, funds=null, companyList=null, figs=null, attaches=null, journal=Journal(id=1302309778002903112, delFlag=0, nameCn=中草药, nameEn=Chinese Traditional and Herbal Drugs, nameHistory1=null, nameHistory2=null, issn=0253-2670, eissn=null, cn=12-1108/R, coden=null, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=cGpSKCP11AF8PAOcTXYWfg==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Traditional and Herbal Drugs, journalRemark=null, publicationField=null, createdTime=1788424446827, updatedTime=1788949289390, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=cGpSKCP11AF8PAOcTXYWfg==, picEn=Xw//kxUC3ON4eHxev0QLhQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1304511127375863983, language=CN, name=中草药, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788949289411, updatedTime=1788949289411, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://www.tiprpress.com/zcy/author/login, submissionEditorUrl=https://www.tiprpress.com/zcy/editor/login, submissionReviewUrl=https://www.tiprpress.com/zcy/reviewer/login, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304511127442972848, language=EN, name=Chinese Traditional and Herbal Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788949289427, updatedTime=1788949289427, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://www.tiprpress.com/zcy/author/login, submissionEditorUrl=https://www.tiprpress.com/zcy/editor/login, submissionReviewUrl=https://www.tiprpress.com/zcy/reviewer/login, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1302319053441957962, websiteList=[Website(id=1302319176408912052, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1302319053441957962, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zcy/CN, language=CN, createTime=1788426687576, createBy=18614031015, updateTime=1788427346252, updateBy=18614031015, name=中草药-中文, tplId=1146099689490845704, title=中草药, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1302322043651904087, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=articleTextType, value=kx, createTime=1788427371180, updateTime=1788427371180, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043593183828, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=banner, value=null, createTime=1788427371166, updateTime=1788427371166, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043672875610, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=grayFlag, value=0, createTime=1788427371185, updateTime=1788427371185, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043584795219, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=logo, value=https://castjournals.cast.org.cn/joweb/zcy/CN/file/pic?fileId=uiD1gpiRqR++OLOz4iKzDg==, createTime=1788427371164, updateTime=1788427371164, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043689652828, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=minRunFlag, value=0, createTime=1788427371189, updateTime=1788427371189, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043643515478, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zcy/CN/file/pic, createTime=1788427371178, updateTime=1788427371178, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043681264219, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=silenceFlag, value=0, createTime=1788427371187, updateTime=1788427371187, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043601572437, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1788427371168, updateTime=1788427371168, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043660292696, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=themeColor, value=null, createTime=1788427371182, updateTime=1788427371182, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043668681305, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=themeStyle, value=null, createTime=1788427371184, updateTime=1788427371184, creator=18614031015, updator=18614031015)]), Website(id=1302319176715096246, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1302319053441957962, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zcy/EN, language=EN, createTime=1788426687649, createBy=18614031015, updateTime=1788427341161, updateBy=18614031015, name=中草药-英文, tplId=1146101810881728533, title=Chinese Traditional and Herbal Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1302322015206134340, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=articleTextType, value=kx, createTime=1788427364398, updateTime=1788427364398, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015185162817, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=banner, value=null, createTime=1788427364393, updateTime=1788427364393, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015227105863, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=grayFlag, value=0, createTime=1788427364403, updateTime=1788427364403, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015176774208, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=logo, value=https://castjournals.cast.org.cn/joweb/zcy/EN/file/pic?fileId=uiD1gpiRqR++OLOz4iKzDg==, createTime=1788427364391, updateTime=1788427364391, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015239688777, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=minRunFlag, value=0, createTime=1788427364406, updateTime=1788427364406, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015201940035, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zcy/EN/file/pic, createTime=1788427364397, updateTime=1788427364397, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015235494472, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=silenceFlag, value=0, createTime=1788427364405, updateTime=1788427364405, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015193551426, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1788427364395, updateTime=1788427364395, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015214522949, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=themeColor, value=null, createTime=1788427364400, updateTime=1788427364400, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015218717254, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=themeStyle, value=null, createTime=1788427364401, updateTime=1788427364401, creator=18614031015, updator=18614031015)])], journalTitle=中草药, weixinUrl=null, journalUrl=https://www.tiprpress.com/zcy, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Traditional and Herbal Drugs, journalPhotoCn=cGpSKCP11AF8PAOcTXYWfg==, journalPhotoEn=Xw//kxUC3ON4eHxev0QLhQ==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501j.issn.0253-2670.2026.19.030, detailUrlEn=https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501j.issn.0253-2670.2026.19.030, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zcy/CN/PDF/10.7501j.issn.0253-2670.2026.19.030, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zcy/EN/PDF/10.7501j.issn.0253-2670.2026.19.030, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1791734400000, fullTextJson=null, articleText=null, reference=McKinsey & Company. Building the bridge to global innovation [R]. Shanghai: McKinsey & Company, 2025.
Liu S, Hu H X, Ge C H, et al. The rise of China’s pharmaceutical industry from 2015—2024: A decade of innovation [J]. Nat Rev Drug Discov, 2025, 24(10): 738-739.
Frost & Sullivan. White paper on the development of cell and gene therapy industry in China [R]. Shanghai: Frost & Sullivan, 2021.
李荣, 范月蕾, 赵晓勤, 等. 新药研发进展与发展态势分析[J]. 生命科学, 2025, 37(1): 86-96.
徐萍, 许丽, 杨若南, 等. 新药研发发展态势分析[J]. 中国科学院院刊, 2024, 39(5): 821-831.
国务院办公厅. 关于全面深化药品医疗器械监管改革促进医药产业高质量发展的意见[EB/OL]. (2024-12-30) [2026-08-19] https://www.gov.cn/zhengce/content/202501/content_6996115.htm.
国家药品监督管理局. 关于优化创新药临床试验审评审批有关事项的公告(2025年第86号) [EB/OL]. (2025-09-26) [2026-08-19] https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypqtggtg/20250912092255131.html.
国家药品监督管理局. 关于发布《境外药品上市许可持有人指定境内责任人管理暂行规定》的公告(2024年第137号) [EB/OL]. (2024-11-20) [2026-08-19]. https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypqtggtg/20241114172951120.html.
江西省工业和信息化厅. 江西省“十四五”医药产业高质量发展规划[EB/OL]. (2021-10-23) [2026-08-19]. https://www.zgys.gov.cn/ysgxj/c121086/202111/580b6cad0f664a6c816dbbbafd0de99e.shtml.
江西省人民政府. 江西省制造业重点产业链现代化建设“1269”行动计划(2023—2026年) [EB/OL]. (2023-07-12) [2026-08-19]. https://jiangxi.gov.cn/jxsrmzf/szfwj/pc/content/content_1899484497711136768.html.
江西省商务厅. 江西省医药产业专题介绍[EB/OL]. (2024-08-20) [2026-08-19]. https://swt.jiangxi.gov.cn/jxsswt/col/col78322/content/content_1872703925204660224.html.
陈海清, 谢俊俊, 陈雨萍, 等. 江西省中药产业发展的同质化问题和对策研究—以江西省樟树市为例[J]. 药品评价, 2023, 20(10): 1171-1175.
前瞻产业研究院. 2024年江西省医药产业链全景图谱[EB/OL]. (2024-09-14) [2026-08-19]. https://news.qq.com/rain/a/20240914A05TG000.
江西人大新闻网. 关于全面提升科技创新驱动力情况的报告——省人民政府关于落实省人大常委会决定情况的报告摘要[EB/OL]. (2024-10-15) [2026-08-19]. https://jxrd.jxnews.com.cn/system/2024/10/14/020664232.shtml.
江西省人民政府办公厅. 关于提升中药质量促进中医药产业高质量发展的实施意见[EB/OL]. (2023-10-13) [2026-08-19]. https://www.jiangxi.gov.cn/jxsrmzf/zcwj103/pc/content/content_1978723227183550464.html.
江西省药品监督管理局. 关于进一步优化药品审评审批促进医药产业高质量发展的若干措施[EB/OL]. (2024-08-19) [2026-08-19]. https://www.jiangxi.gov.cn/jxsrmzf/2024nd17qzd1255q/pc/content/content_1873555790893002752.html.
江西省工业强省建设工作领导小组. 江西省支持医药产业高质量发展的若干措施[EB/OL]. (2024-10-12) [2026-08-19]. https://gxt.jiangxi.gov.cn/jxsgyhxxht/zcwj107/pc/content/content_1876539320271339530.html.
药智网. 2024中国药品研发综合实力排行榜[EB/OL].重庆: 药智网, (2024-07-04) [2026-08-19]. https://top.yaozh.com/.
颜冬梅, 李娜, 张金莲, 等. 江西传统炮制技术的研究进展[J]. 中药材, 2016, 39(2): 447-450.
周颖, 钟凌云. 江西建昌帮特色炮制品种阴附片与阳附片的工艺及质量标准研究[J]. 时珍国医国药, 2026, 37(10): 1870-1878.
黄东, 易斌, 乐海平, 等. 江西建昌帮特色中药饮片炮制“炆法”浅析[J]. 药品评价, 2021, 18(24): 1525-1528.
徐春娟, 何晓晖. 旴江医家龚廷贤方现代临床应用概况[J]. 中医文献杂志, 2016, 34(4): 68-71.
罗雄, 周剑军. 基于专利信息的江西省中医药技术创新态势研究[J]. 江西科学, 2024, 42(6): 1320-1326.
陈海清, 谢俊俊, 陈雨萍, 等. 江西省中药产业发展竞争力的研究[J]. 药品评价, 2023, 20(12): 1440-1443.
泰和县人民政府办公室. 关于印发泰和县现代农业产业高质量发展三年行动方案(2023—2025年)的通知[EB/OL]. (2023-03-23) [2026-08-19]. https://www.jxth.gov.cn/xxgk-show-10226376.html.
国际标准化组织. 中医药—栀子: ISO 13619:2024[S]. 2024.
吉林省人民政府办公厅. 长白山人参产业高质量发展规划(2025—2030年) [EB/OL]. (2025-03-19) [2026-08-19]. http://agri.jl.gov.cn/hd/yjzj/202503/t20250319_3417644.html.
文山州人民政府办公室. 文山州关于推动三七产业高质量发展的实施方案[EB/OL]. (2025-09-08) [2026-08-19]. https://www.ynws.gov.cn/wszzf/zzfbgswj202503111112/pc/content/content_1981279612656001024.html.
李雪. 苏州工业园区生物医药产业集群的演化机理研究[D]. 苏州: 苏州大学, 2022.
Frost & Sullivan. Independent Market Research Report on Antibody Drugs, Anesthetic Drugs, and Parenteral Nutrition Drugs [R]. Shanghai: Frost & Sullivan, 2021.)
收藏切换
全球竞争视角下创新药产业重点赛道发展策略——江西省中药现代化转型与生物药/抗体药物协同创新路径
收藏切换
PDF下载
中草药 | 综述 2026,57(19): 7877-7885
收起
收藏切换
中草药 |综述 2026 , 57 (19) : 7877 -7885
全球竞争视角下创新药产业重点赛道发展策略——江西省中药现代化转型与生物药/抗体药物协同创新路径
全屏
杨苏瓃鑫1, 李婧媛1, 王美林2, 陈林1, 周翔3, 杨明3, 汪仕勇4, 陈士林1
作者信息
    1 成都中医药大学, 四川 成都 611137;
    2 西南民族大学, 四川 成都 610041;
    3 江西中医药大学, 江西 南昌 330004;
    4 江西省科技信息研究所, 江西 南昌 330046
通讯作者:
陈士林
作者简介:
杨苏瓃鑫: 杨苏瓃鑫,副研究员,硕士生导师,从事药物化学与递送系统开发研究。E-mail:yangsulation@cdutcm.edu.cn 李婧媛: 李婧媛,硕士研究生,研究方向为中医药与现代生物学交叉。E-mail:lijingyuan2025@163.com
Key strategies for innovative drug development in global competition: Jiangxi’s traditional Chinese medicine modernization and biologics/antibody collaborative innovation
  • YANG Suleixin1, LI Jingyuan1, WANG Meilin2, CHEN Lin1, ZHOU Xiang3, YANG Ming3, WANG Shiyong4, CHEN Shilin1
  • Affiliations
      1 Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China;
      2 Southwest Minzu University, Chengdu 610041, China;
      3 Jiangxi University of Chinese Medicine, Nanchang 330004, China;
      4 Jiangxi Institute of Scientific & Technical Information, Nanchang 330046, China
    doi: 10.7501j.issn.0253-2670.2026.19.030
    文章导航
    收藏切换
    在全球生物医药创新加速与中国医药产业向创新驱动转型的背景下,江西省依托深厚的中医药底蕴和“一城一都多园”的产业基础,迎来发展机遇,但也面临生物药与抗体药物等新兴领域规模偏小、高端要素集聚不足、成果转化效率不高等突出问题。运用文献研究、案例分析与比较研究等方法,系统评估了江西省创新药产业的发展现状与核心短板,进而提出“中药现代化为根基,生物药与抗体药物错位协同”的差异化发展路径。建议江西应重点推动中药全产业链数智升级与标准化,培育百亿级大品种,聚焦细胞治疗、抗体-药物偶联物等赛道实施梯度布局,并通过构建“人才-资本-平台-政策”协同的创新生态,强化临床转化与金融支撑,实现从“医药大省”到“医药强省”的跨越。
    江西省  /  创新药  /  中医药现代化  /  生物制品/抗体药物  /  全球视角
    Against the backdrop of accelerated innovation in the global biomedical sector and China’s transition toward innovation-driven development in the pharmaceutical industry, Jiangxi province—with its profound traditional Chinese medicine heritage and industrial foundation characterized by “one city, one capital, and multiple parks”—faces both opportunities and challenges. Prominent issues include the relatively small scale of emerging fields such as biologics and antibody drugs, insufficient clustering of high-end innovation factors, and low efficiency in translating research outcomes into applications. To study these challenges, this study employs methods such as literature review, case analysis, and comparative research to systematically assess the current status and core weaknesses of Jiangxi’s innovative drug industry. It further proposes a differentiated development pathway centered on “modernizing traditional Chinese medicine as the foundation while promoting differentiated and coordinated development of biologics and antibody drugs.” The study recommends that Jiangxi should focus on advancing the digital and intelligent transformation and standardization of the entire TCM industry chain, cultivate blockbuster pharmaceutical products with a market scale of RMB 10 billion, implement a gradient layout in key areas such as cell therapy and antibody-drug conjugate drugs, and build a synergistic innovation ecosystem integrating “talent, capital, platforms, and policies,” with strengthened clinical translation and financial support. These measures will enable the transition from a “major pharmaceutical province” to a “strong pharmaceutical province.”
    Jiangxi province  /  innovative drugs  /  modernization of traditional Chinese medicine  /  biologics/antibody drugs  /  global perspective
    杨苏瓃鑫, 李婧媛, 王美林, 陈林, 周翔, 杨明, 汪仕勇, 陈士林. 全球竞争视角下创新药产业重点赛道发展策略——江西省中药现代化转型与生物药/抗体药物协同创新路径. 中草药, 2026 , 57 (19) : 7877 -7885 . DOI: 10.7501j.issn.0253-2670.2026.19.030
    YANG Suleixin, LI Jingyuan, WANG Meilin, CHEN Lin, ZHOU Xiang, YANG Ming, WANG Shiyong, CHEN Shilin. Key strategies for innovative drug development in global competition: Jiangxi’s traditional Chinese medicine modernization and biologics/antibody collaborative innovation[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (19) : 7877 -7885 . DOI: 10.7501j.issn.0253-2670.2026.19.030

      中国工程院咨询项目“江西省创新药重点发展方向及布局研究” (2025-02JXZD-05)

    参考文献 引证文献
    排序方式:
    McKinsey & Company. Building the bridge to global innovation [R]. Shanghai: McKinsey & Company, 2025.
    Liu S, Hu H X, Ge C H, et al. The rise of China’s pharmaceutical industry from 2015—2024: A decade of innovation [J]. Nat Rev Drug Discov, 2025, 24(10): 738-739.
    Frost & Sullivan. White paper on the development of cell and gene therapy industry in China [R]. Shanghai: Frost & Sullivan, 2021.
    李荣, 范月蕾, 赵晓勤, 等. 新药研发进展与发展态势分析[J]. 生命科学, 2025, 37(1): 86-96.
    徐萍, 许丽, 杨若南, 等. 新药研发发展态势分析[J]. 中国科学院院刊, 2024, 39(5): 821-831.
    国务院办公厅. 关于全面深化药品医疗器械监管改革促进医药产业高质量发展的意见[EB/OL]. (2024-12-30) [2026-08-19] https://www.gov.cn/zhengce/content/202501/content_6996115.htm.
    国家药品监督管理局. 关于优化创新药临床试验审评审批有关事项的公告(2025年第86号) [EB/OL]. (2025-09-26) [2026-08-19] https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypqtggtg/20250912092255131.html.
    国家药品监督管理局. 关于发布《境外药品上市许可持有人指定境内责任人管理暂行规定》的公告(2024年第137号) [EB/OL]. (2024-11-20) [2026-08-19]. https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypqtggtg/20241114172951120.html.
    江西省工业和信息化厅. 江西省“十四五”医药产业高质量发展规划[EB/OL]. (2021-10-23) [2026-08-19]. https://www.zgys.gov.cn/ysgxj/c121086/202111/580b6cad0f664a6c816dbbbafd0de99e.shtml.
    江西省人民政府. 江西省制造业重点产业链现代化建设“1269”行动计划(2023—2026年) [EB/OL]. (2023-07-12) [2026-08-19]. https://jiangxi.gov.cn/jxsrmzf/szfwj/pc/content/content_1899484497711136768.html.
    江西省商务厅. 江西省医药产业专题介绍[EB/OL]. (2024-08-20) [2026-08-19]. https://swt.jiangxi.gov.cn/jxsswt/col/col78322/content/content_1872703925204660224.html.
    陈海清, 谢俊俊, 陈雨萍, 等. 江西省中药产业发展的同质化问题和对策研究—以江西省樟树市为例[J]. 药品评价, 2023, 20(10): 1171-1175.
    前瞻产业研究院. 2024年江西省医药产业链全景图谱[EB/OL]. (2024-09-14) [2026-08-19]. https://news.qq.com/rain/a/20240914A05TG000.
    江西人大新闻网. 关于全面提升科技创新驱动力情况的报告——省人民政府关于落实省人大常委会决定情况的报告摘要[EB/OL]. (2024-10-15) [2026-08-19]. https://jxrd.jxnews.com.cn/system/2024/10/14/020664232.shtml.
    江西省人民政府办公厅. 关于提升中药质量促进中医药产业高质量发展的实施意见[EB/OL]. (2023-10-13) [2026-08-19]. https://www.jiangxi.gov.cn/jxsrmzf/zcwj103/pc/content/content_1978723227183550464.html.
    江西省药品监督管理局. 关于进一步优化药品审评审批促进医药产业高质量发展的若干措施[EB/OL]. (2024-08-19) [2026-08-19]. https://www.jiangxi.gov.cn/jxsrmzf/2024nd17qzd1255q/pc/content/content_1873555790893002752.html.
    江西省工业强省建设工作领导小组. 江西省支持医药产业高质量发展的若干措施[EB/OL]. (2024-10-12) [2026-08-19]. https://gxt.jiangxi.gov.cn/jxsgyhxxht/zcwj107/pc/content/content_1876539320271339530.html.
    药智网. 2024中国药品研发综合实力排行榜[EB/OL].重庆: 药智网, (2024-07-04) [2026-08-19]. https://top.yaozh.com/.
    颜冬梅, 李娜, 张金莲, 等. 江西传统炮制技术的研究进展[J]. 中药材, 2016, 39(2): 447-450.
    周颖, 钟凌云. 江西建昌帮特色炮制品种阴附片与阳附片的工艺及质量标准研究[J]. 时珍国医国药, 2026, 37(10): 1870-1878.
    黄东, 易斌, 乐海平, 等. 江西建昌帮特色中药饮片炮制“炆法”浅析[J]. 药品评价, 2021, 18(24): 1525-1528.
    徐春娟, 何晓晖. 旴江医家龚廷贤方现代临床应用概况[J]. 中医文献杂志, 2016, 34(4): 68-71.
    罗雄, 周剑军. 基于专利信息的江西省中医药技术创新态势研究[J]. 江西科学, 2024, 42(6): 1320-1326.
    陈海清, 谢俊俊, 陈雨萍, 等. 江西省中药产业发展竞争力的研究[J]. 药品评价, 2023, 20(12): 1440-1443.
    泰和县人民政府办公室. 关于印发泰和县现代农业产业高质量发展三年行动方案(2023—2025年)的通知[EB/OL]. (2023-03-23) [2026-08-19]. https://www.jxth.gov.cn/xxgk-show-10226376.html.
    国际标准化组织. 中医药—栀子: ISO 13619:2024[S]. 2024.
    吉林省人民政府办公厅. 长白山人参产业高质量发展规划(2025—2030年) [EB/OL]. (2025-03-19) [2026-08-19]. http://agri.jl.gov.cn/hd/yjzj/202503/t20250319_3417644.html.
    文山州人民政府办公室. 文山州关于推动三七产业高质量发展的实施方案[EB/OL]. (2025-09-08) [2026-08-19]. https://www.ynws.gov.cn/wszzf/zzfbgswj202503111112/pc/content/content_1981279612656001024.html.
    李雪. 苏州工业园区生物医药产业集群的演化机理研究[D]. 苏州: 苏州大学, 2022.
    Frost & Sullivan. Independent Market Research Report on Antibody Drugs, Anesthetic Drugs, and Parenteral Nutrition Drugs [R]. Shanghai: Frost & Sullivan, 2021.
    2026年第57卷第19期
    PDF下载
    39
    10
    引用本文
    BibTeX
    文章信息
    doi: 10.7501j.issn.0253-2670.2026.19.030
    • 接收时间:2026-05-26
    • 首发时间:2026-10-29
    补充材料
    相关文章
    文章信息
    作者
    出版历史
    • 收稿日期:2026-05-26
    基金
    作者信息
    参考文献
    分享链接
    https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501j.issn.0253-2670.2026.19.030
    分享至
    全文二维码

    扫描看全文

    引用本文
    BibTeX
    本文的引用情况
    2种不同金属材料的力学参数
    科
    Family
    属数
    Number of
    genus
    种数
    Number of
    species
    占总种数比例
    Percentage of
    total species (%)
    属
    Genus
    种数
    Number of
    species
    占总种数比例
    Percentage of total
    species (%)
    鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
    小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
    多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
    红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
    小菇属 Mycena 11 5.26
    光柄菇属 Pluteus 5 2.39
    红菇属 Russula 17 8.13
    栓菌属 Trametes 5 2.39
    关闭全屏